Abstract
This review imparts a survey on the synthesis and reactions of ethylidenethiosemicarbazides as well as their biological activities during the period from 2005 to 2015. The synthetic utilities of ethylidenethiosemicarbazides, as building blocks, for the synthesis of various heterocyclic compounds such as azoles, azines, and fused ring systems, have been demonstrated.
Keywords: Ethylidenethiosemicarbazides, heterocycles, cyclocondensation, arylazothiazole, biological activity.
Graphical Abstract
Current Organic Synthesis
Title:Utility of Ethylidenethiosemicarbazides in Heterocyclic Synthesis
Volume: 14 Issue: 1
Author(s): Sayed M. Riyadh, Sobhi M. Gomha and Elmahdi A. Mahmmoud
Affiliation:
Keywords: Ethylidenethiosemicarbazides, heterocycles, cyclocondensation, arylazothiazole, biological activity.
Abstract: This review imparts a survey on the synthesis and reactions of ethylidenethiosemicarbazides as well as their biological activities during the period from 2005 to 2015. The synthetic utilities of ethylidenethiosemicarbazides, as building blocks, for the synthesis of various heterocyclic compounds such as azoles, azines, and fused ring systems, have been demonstrated.
Export Options
About this article
Cite this article as:
Riyadh M. Sayed, Gomha M. Sobhi and Mahmmoud A. Elmahdi, Utility of Ethylidenethiosemicarbazides in Heterocyclic Synthesis, Current Organic Synthesis 2017; 14 (1) . https://dx.doi.org/10.2174/1570179413666151218202004
DOI https://dx.doi.org/10.2174/1570179413666151218202004 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Strategies to Control Human Lymphatic Filarial Infection: Tweaking Host’s Immune System
Current Topics in Medicinal Chemistry Squalene as Novel Food Factor
Current Pharmaceutical Biotechnology Role of Chemokines and Trafficking of Immune Cells in Parasitic Infections
Current Immunology Reviews (Discontinued) Editorial [Hot Topic: Pharmaceutical and Cellular Strategies of Recent Advances in Immunotherapy (Executive Editors: George Tuszynski and Mahesh Sharma)]
Current Pharmaceutical Design Development of Montelukast Sodium Loaded Niosomal Carriers by Film Hydration Technique
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Acknowledgements to Reviewers
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Acetyl-L-Carnitine Modulates TP53 and IL10 Gene Expression Induced by 3-NPA Evoked Toxicity in PC12 Cells
Current Neuropharmacology IL-27: Friend or Foe in the Autoimmune Diseases
Current Immunology Reviews (Discontinued) B Cell Depletion in Systemic Vasculitis
Current Immunology Reviews (Discontinued) The Effects of Vitamin B in Depression
Current Medicinal Chemistry Advances in the Development of Bradykinin Receptor Ligands
Current Topics in Medicinal Chemistry Biological Effects of Licochalcones
Mini-Reviews in Medicinal Chemistry Antiviral Drugs in the Prophylaxis of HBV Infection
Current Medicinal Chemistry Pathogenetic Pathways of Cardiorenal Syndrome and their Possible Therapeutic Implications
Current Pharmaceutical Design The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
Current Medicinal Chemistry Cannabis-Derived Substances in Cancer Therapy – An Emerging Anti- Inflammatory Role for the Cannabinoids
Current Clinical Pharmacology BMPS and Liver: More Questions than Answers
Current Pharmaceutical Design Medicinal Chemistry and Anti-Inflammatory Activity of Nitric Oxide-Releasing NSAI Drugs
Mini-Reviews in Medicinal Chemistry Synthetic Sphingosine 1-Phosphate Receptor Modulators - Opportunities and Potential Pitfalls
Current Topics in Medicinal Chemistry New Frontiers in the Therapeutic Management of Transplant Rejection
Current Pharmaceutical Design